Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MDR Vivacit-E Elevated Study

NCT: NCT07150221 · ENROLLING_BY_INVITATION

NCT IDNCT07150221
StatusENROLLING_BY_INVITATION
Start Date2026-01-07
Completion2027-12

Brief Summary

The main objective of this study is to confirm long-term safety, performance, and clinical benefits of the Vivacit-E Vitamin E HXLPE Elevated Liners when used in primary total hip arthroplasty.

Frequently Asked Questions

What is MDR Vivacit-E Elevated Study?

MDR Vivacit-E Elevated Study is a clinical trial registered under NCT07150221. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07150221?

The current status of NCT07150221 (MDR Vivacit-E Elevated Study) is: ENROLLING_BY_INVITATION.

When did MDR Vivacit-E Elevated Study start?

MDR Vivacit-E Elevated Study started on 2026-01-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.